|
US7135584B2
(en)
*
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
|
EP1852121A3
(en)
*
|
1994-08-29 |
2007-11-21 |
Wake Forest University |
Lipid analogs for treating viral infections
|
|
UA72558C2
(uk)
*
|
1999-11-01 |
2005-03-15 |
Мерц Фарма Гмбх Унд Ко. Кгаа |
1-аміноалкілциклогексанові антагоністи рецептора nmda
|
|
US6444702B1
(en)
|
2000-02-22 |
2002-09-03 |
Neuromolecular, Inc. |
Aminoadamantane derivatives as therapeutic agents
|
|
PY0111577A
(es)
|
2000-05-23 |
2017-01-02 |
Idenix Cayman Ltd |
Métodos y composiciones para el tratamiento del virus de la hepatitis c
|
|
BR0111196A
(pt)
|
2000-05-26 |
2004-04-06 |
Idenix Cayman Ltd |
Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
|
|
TW593223B
(en)
*
|
2000-06-20 |
2004-06-21 |
Merz Pharma Gmbh & Co Kgaa |
1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
|
|
US6602862B1
(en)
*
|
2000-09-19 |
2003-08-05 |
Merz Pharma Gmbh & Co., Kgaa |
1-Amino-alkylcyclohexanes as trypanocidal agents
|
|
CN101862345B
(zh)
|
2000-10-18 |
2014-06-04 |
吉利德制药有限责任公司 |
用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物
|
|
WO2002044717A1
(en)
*
|
2000-12-01 |
2002-06-06 |
Cornell Research Foundation |
Animal model for flaviviridae infection
|
|
EP1366055A2
(en)
*
|
2000-12-15 |
2003-12-03 |
Pharmasset Limited |
Antiviral agents for treatment of flaviviridae infections
|
|
JP2005506292A
(ja)
*
|
2001-03-08 |
2005-03-03 |
エモリー ユニバーシティ |
pHに依存するNMDAレセプターアンタゴニスト
|
|
JP2005504087A
(ja)
*
|
2001-09-28 |
2005-02-10 |
イデニクス(ケイマン)リミテツド |
4’が修飾されたヌクレオシドを使用するc型肝炎ウイルス治療のための方法および組成物
|
|
US6828462B2
(en)
*
|
2001-11-07 |
2004-12-07 |
Merz Pharma Gmbh & Co. Kgaa |
Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
|
|
CA2476279A1
(en)
*
|
2002-02-14 |
2003-08-21 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
|
CN104193791A
(zh)
|
2002-06-28 |
2014-12-10 |
埃迪尼克斯医药公司 |
用于治疗黄病毒感染的修饰的2’和3’-核苷前药
|
|
AU2003251993A1
(en)
*
|
2002-07-19 |
2004-02-09 |
Inge Grundke-Iqbal |
NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau
|
|
CA2494340C
(en)
*
|
2002-08-01 |
2012-01-24 |
Pharmasset Inc. |
Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections
|
|
EP2260839A3
(en)
|
2002-10-24 |
2012-05-02 |
Merz Pharma GmbH & Co. KGaA |
Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
|
|
RU2005118421A
(ru)
|
2002-11-15 |
2006-01-20 |
Айденикс (Кайман) Лимитед (Ky) |
2'-разветвленные нуклеозиды и мутация flaviviridae
|
|
US7732162B2
(en)
|
2003-05-05 |
2010-06-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
|
|
AU2004251636B2
(en)
*
|
2003-05-27 |
2006-11-09 |
Merz Pharma Gmbh & Co. Kgaa |
Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
|
|
WO2005003147A2
(en)
|
2003-05-30 |
2005-01-13 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
|
AU2004258750A1
(en)
*
|
2003-07-25 |
2005-02-03 |
Centre National De La Recherche Scientifique -Cnrs |
Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis C
|
|
CA2529674A1
(en)
*
|
2003-07-28 |
2005-02-03 |
Merz Pharma Gmbh & Co. Kgaa |
The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity
|
|
US20050113458A1
(en)
*
|
2003-10-22 |
2005-05-26 |
Forest Laboratories, Inc. |
Use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic a-beta peptides in amyloidopathies
|
|
AR046314A1
(es)
|
2003-11-05 |
2005-11-30 |
Merz Pharma Gmbh & Co Kgaa |
Composiciones que comprenden ciclohexilaminas y aminoadamantanos
|
|
UY28650A1
(es)
*
|
2003-12-05 |
2005-02-28 |
Forest Laboratories |
Memantina para la prevencion o disminucion de la conducta suicida y para el tratamiento de la depresion mayor asociada con esta conducta
|
|
GB0500020D0
(en)
|
2005-01-04 |
2005-02-09 |
Novartis Ag |
Organic compounds
|
|
PL1703902T3
(pl)
*
|
2004-01-05 |
2011-04-29 |
Merz Pharma Gmbh & Co Kgaa |
Memantyna do leczenia choroby Alzheimera o łagodnym do umiarkowanego stopniu zaawansowania
|
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
|
TW200531680A
(en)
*
|
2004-03-03 |
2005-10-01 |
Merz Pharma Gmbh & Co Kgaa |
Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
|
|
US20060002999A1
(en)
*
|
2004-06-17 |
2006-01-05 |
Forest Laboratories, Inc. |
Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
|
|
MXPA06014587A
(es)
*
|
2004-06-17 |
2007-04-27 |
Forest Laboratories |
Formulaciones de liberacion modificada de formulaciones de dosificacion oral de memantina.
|
|
EP2397122B1
(en)
*
|
2004-06-17 |
2014-05-14 |
Merz Pharma GmbH & Co. KGaA |
Formulations of neramexane dosage forms
|
|
JP2008503562A
(ja)
*
|
2004-06-23 |
2008-02-07 |
イデニクス(ケイマン)リミテツド |
フラビウイルス科による感染症を治療するための5−アザ−7−デアザプリン誘導体
|
|
CN101023094B
(zh)
*
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
|
MX2007003085A
(es)
|
2004-09-14 |
2007-08-02 |
Pharmasset Inc |
Preparacion de 2'-fluoro-2'-alquilo sustituido u otras ribofuranosil pirimidinas y purinas opcionalmente sustituidas y sus derivados.
|
|
TW200621677A
(en)
*
|
2004-09-21 |
2006-07-01 |
Astellas Pharma Inc |
Cyclic amine derivative or salt thereof
|
|
US20060205822A1
(en)
*
|
2004-12-22 |
2006-09-14 |
Forest Laboratories, Inc. |
1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
|
|
EP1898890A1
(en)
*
|
2005-06-16 |
2008-03-19 |
Forest Laboratories, Inc. |
Modified and immediate release memantine bead formulation
|
|
US20070099947A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Alkermes, Inc. |
Methods and compositions for the treatment of brain reward system disorders by combination therapy
|
|
US20070141148A1
(en)
*
|
2005-11-30 |
2007-06-21 |
Merz Pharma Gmbh & Co. Kgaa |
Neramexane MR matrix tablet
|
|
RU2448976C2
(ru)
|
2006-04-11 |
2012-04-27 |
Новартис Аг |
Ингибиторы hcv/вич и их применение
|
|
US20080008743A1
(en)
*
|
2006-07-06 |
2008-01-10 |
Forest Laboratories Holdings Limited |
Orally Dissolving Formulations of Memantine
|
|
ES2412384T3
(es)
|
2006-07-18 |
2013-07-11 |
Astellas Pharma Inc. |
Derivado de aminoindano o sal del mismo
|
|
DE602007011773D1
(de)
|
2006-08-04 |
2011-02-17 |
Merz Pharma Gmbh & Co Kgaa |
Substituierte pyrazolopyrimidine, ein verfahren zu ihrer herstellung und ihre verwendung als medizin
|
|
US8278345B2
(en)
|
2006-11-09 |
2012-10-02 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
|
US9126987B2
(en)
|
2006-11-30 |
2015-09-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
|
HRP20110713T1
(hr)
*
|
2007-02-28 |
2011-11-30 |
Conatus Pharmaceuticals |
Postupci liječenja kroničnog virusnog hepatitisa c uz upotrebu ro 113-0830
|
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
|
JP5930573B2
(ja)
|
2007-03-01 |
2016-06-15 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤の新規使用
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
JP5667440B2
(ja)
|
2007-04-18 |
2015-02-12 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
|
|
TW200916091A
(en)
*
|
2007-06-08 |
2009-04-16 |
Merz Pharma Gmbh & Amp Co Kgaa |
Neramexane for the treatment of nystagmus
|
|
EA201070077A1
(ru)
*
|
2007-06-29 |
2010-08-30 |
Эмори Юниверсити |
Антагонисты nmda-рецепторов с нейропротективным действием
|
|
EP2018854A1
(en)
*
|
2007-07-27 |
2009-01-28 |
Merz Pharma GmbH & Co. KGaA |
Novel combinations of neramexane for the treatment of neurodegenerative disorders
|
|
HRP20120046T1
(hr)
*
|
2007-09-12 |
2012-02-29 |
Merz Pharma Gmbh & Co. Kgaa |
Nerameksan za uporabu kod liječenja subakutnog tinitusa
|
|
RU2438658C2
(ru)
*
|
2007-09-12 |
2012-01-10 |
Мерц Фарма Гмбх Унд Ко. Кгаа |
Производные 1-аминоалкилциклогексана для лечения кохлеарного тиннитуса
|
|
EP2090576A1
(en)
|
2008-02-01 |
2009-08-19 |
Merz Pharma GmbH & Co.KGaA |
6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
|
|
EP2085398A1
(en)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidines, a process for their preparation and their use as medicine
|
|
TW200946541A
(en)
*
|
2008-03-27 |
2009-11-16 |
Idenix Pharmaceuticals Inc |
Solid forms of an anti-HIV phosphoindole compound
|
|
WO2009151498A2
(en)
*
|
2008-03-28 |
2009-12-17 |
Forest Laboratories Holdings Limited |
Memantine formulations
|
|
EP2288345B1
(en)
|
2008-04-18 |
2015-06-10 |
University College Dublin National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
EP2111858A1
(en)
|
2008-04-25 |
2009-10-28 |
EPFL Ecole Polytechnique Fédérale de Lausanne |
Novel treatment for alzheimer's disease
|
|
US20090275597A1
(en)
*
|
2008-05-02 |
2009-11-05 |
Forest Laboratories Holdings Limited |
Methods of treating cns disorders
|
|
US8173621B2
(en)
*
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
TW201010691A
(en)
*
|
2008-06-12 |
2010-03-16 |
Merz Pharma Gmbh & Co Kgaa |
1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
|
|
TW201006463A
(en)
*
|
2008-06-26 |
2010-02-16 |
Merz Pharma Gmbh & Co Kgaa |
Pharmaceutical compositions comprising aminocyclohexane derivatives
|
|
CN102177172A
(zh)
|
2008-07-02 |
2011-09-07 |
埃迪尼克斯医药公司 |
用于治疗病毒感染的化合物和药物组合物
|
|
UA105182C2
(ru)
|
2008-07-03 |
2014-04-25 |
Ньюрексон, Інк. |
Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
|
|
JP5385402B2
(ja)
*
|
2008-12-19 |
2014-01-08 |
メルツ・ファルマ・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト・アウフ・アクティーン |
肥満細胞媒介疾患を治療するための1−アミノ−アルキルシクロヘキサン誘導体
|
|
TWI432188B
(zh)
|
2008-12-19 |
2014-04-01 |
Merz Pharma Gmbh & Co Kgaa |
供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類
|
|
AR074897A1
(es)
|
2008-12-23 |
2011-02-23 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
|
WO2010075554A1
(en)
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Synthesis of purine nucleosides
|
|
WO2010075517A2
(en)
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Nucleoside analogs
|
|
EP2403860B1
(en)
|
2009-03-04 |
2015-11-04 |
IDENIX Pharmaceuticals, Inc. |
Phosphothiophene and phosphothiazole as hcv polymerase inhibitors
|
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
|
KR20120006059A
(ko)
*
|
2009-04-17 |
2012-01-17 |
메르츠 파마 게엠베하 운트 코. 카가아 |
1-아미노-1,3,3,5,5-펜타메틸사이클로헥산 메실레이트의 합성
|
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
EP2448896B1
(en)
*
|
2009-06-29 |
2014-03-12 |
Merz Pharma GmbH & Co. KGaA |
Method of preparing 1-hydroxy-1,3,3,5,5-pentamethylcyclohexane
|
|
JP5749261B2
(ja)
*
|
2009-06-29 |
2015-07-15 |
メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー |
3,3,5,5−テトラメチルシクロヘキサノンを調製する方法
|
|
US8759581B2
(en)
|
2009-06-29 |
2014-06-24 |
Merz Pharma Gmbh & Co. Kgaa |
Method of preparing 1-chloroacetamido-1,3,3,5,5-pentamethylcyclohexane
|
|
TW201116532A
(en)
|
2009-08-05 |
2011-05-16 |
Merz Pharma Gmbh & Co Kgaa |
Metabotropic glutamate receptor modulators
|
|
US9284307B2
(en)
|
2009-08-05 |
2016-03-15 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors
|
|
PL2475428T3
(pl)
|
2009-09-11 |
2015-12-31 |
Probiodrug Ag |
Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
|
|
WO2011035924A1
(en)
*
|
2009-09-28 |
2011-03-31 |
Merz Pharma Gmbh & Co. Kgaa |
Method of preparing neramexane or a salt thereof
|
|
US20110117055A1
(en)
|
2009-11-19 |
2011-05-19 |
Macdonald James E |
Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
|
|
CA2784748A1
(en)
|
2009-12-18 |
2011-06-23 |
Idenix Pharmaceuticals, Inc. |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
|
EP2542549B1
(en)
|
2010-03-03 |
2016-05-11 |
Probiodrug AG |
Inhibitors of glutaminyl cyclase
|
|
US8269019B2
(en)
|
2010-03-10 |
2012-09-18 |
Probiodrug Ag |
Inhibitors
|
|
RS54368B1
(sr)
|
2010-03-31 |
2016-04-28 |
Gilead Pharmasset Llc |
Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-diokso-3,4-dihidropirimidin-1-(2h)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat
|
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
|
CN102917585A
(zh)
|
2010-04-01 |
2013-02-06 |
埃迪尼克斯医药公司 |
用于治疗病毒感染的化合物和药物组合物
|
|
US8541596B2
(en)
|
2010-04-21 |
2013-09-24 |
Probiodrug Ag |
Inhibitors
|
|
US20110294890A1
(en)
|
2010-05-28 |
2011-12-01 |
Merz Pharma Gmbh & Co. Kgaa |
Neramexane for the treatment or prevention of inner ear disorders
|
|
KR20130087379A
(ko)
*
|
2010-06-18 |
2013-08-06 |
메르츠 파마 게엠베하 운트 코. 카가아 |
1-아미노-알킬시클로헥산 유도체의 국소 사용을 위한 겔 제형
|
|
US9011833B2
(en)
|
2010-10-08 |
2015-04-21 |
Novartis Ag |
Vitamin E formulations of sulfamide NS3 inhibitors
|
|
WO2012048871A1
(en)
|
2010-10-12 |
2012-04-19 |
Merz Pharma Gmbh & Co. Kgaa |
Memantine for improving cognitive performance in subjects
|
|
EP3042910B1
(en)
|
2010-11-30 |
2019-01-09 |
Gilead Pharmasset LLC |
2'-spiro-nucleosides for use in the therapy of hepatitis c
|
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
|
WO2012098000A1
(en)
|
2011-01-20 |
2012-07-26 |
Merz Pharma Gmbh & Co. Kgaa |
Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss
|
|
AR085352A1
(es)
|
2011-02-10 |
2013-09-25 |
Idenix Pharmaceuticals Inc |
Inhibidores macrociclicos de serina proteasa, sus composiciones farmaceuticas y su uso para tratar infecciones por hcv
|
|
WO2012107584A1
(en)
|
2011-02-11 |
2012-08-16 |
Universite Pierre Et Marie Curie (Paris 6) |
Methods for predicting outcome of a hepatitis virus infection
|
|
US8530670B2
(en)
|
2011-03-16 |
2013-09-10 |
Probiodrug Ag |
Inhibitors
|
|
CA2843324A1
(en)
|
2011-03-31 |
2012-11-15 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
|
EP2739301B1
(en)
|
2011-08-03 |
2016-01-20 |
Cytheris |
Hcv immunotherapy
|
|
TW201329096A
(zh)
|
2011-09-12 |
2013-07-16 |
Idenix Pharmaceuticals Inc |
經取代羰氧基甲基磷酸醯胺化合物及用於治療病毒感染之藥學組成物
|
|
CN103906759A
(zh)
|
2011-09-12 |
2014-07-02 |
埃迪尼克斯医药公司 |
用于治疗病毒感染的化合物和药物组合物
|
|
WO2013056046A1
(en)
|
2011-10-14 |
2013-04-18 |
Idenix Pharmaceuticals, Inc. |
Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
|
EP3750544B1
(en)
|
2011-11-30 |
2025-03-05 |
Emory University |
Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae
|
|
US8809354B2
(en)
|
2011-12-31 |
2014-08-19 |
Sheikh Riazuddin |
3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
|
|
WO2013133927A1
(en)
|
2012-02-13 |
2013-09-12 |
Idenix Pharmaceuticals, Inc. |
Pharmaceutical compositions of 2'-c-methyl-guanosine, 5'-[2-[(3-hydroxy-2,2-dimethyl-1-oxopropyl)thio]ethyl n-(phenylmethyl)phosphoramidate]
|
|
EP2852603B1
(en)
|
2012-05-22 |
2021-05-12 |
Idenix Pharmaceuticals LLC |
D-amino acid compounds for liver disease
|
|
US9109001B2
(en)
|
2012-05-22 |
2015-08-18 |
Idenix Pharmaceuticals, Inc. |
3′,5′-cyclic phosphoramidate prodrugs for HCV infection
|
|
EP2852605B1
(en)
|
2012-05-22 |
2018-01-31 |
Idenix Pharmaceuticals LLC |
3',5'-cyclic phosphate prodrugs for hcv infection
|
|
RU2488388C1
(ru)
*
|
2012-05-24 |
2013-07-27 |
Ооо "Валента Интеллект" |
Фармацевтическая композиция для профилактики и лечения психических, поведенческих, когнитивных расстройств
|
|
UA107653U
(uk)
|
2012-10-01 |
2016-06-24 |
Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" |
Композиція лікарських засобів для лікування та профілактики поведінкових, психічних та когнітивних розладів
|
|
SG11201502750UA
(en)
|
2012-10-08 |
2015-06-29 |
Idenix Pharmaceuticals Inc |
2'-chloro nucleoside analogs for hcv infection
|
|
WO2014063019A1
(en)
|
2012-10-19 |
2014-04-24 |
Idenix Pharmaceuticals, Inc. |
Dinucleotide compounds for hcv infection
|
|
EP2909222B1
(en)
|
2012-10-22 |
2021-05-26 |
Idenix Pharmaceuticals LLC |
2',4'-bridged nucleosides for hcv infection
|
|
US20140140952A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-Alanine Ester of Sp-Nucleoside Analog
|
|
EP2920195A1
(en)
|
2012-11-14 |
2015-09-23 |
IDENIX Pharmaceuticals, Inc. |
D-alanine ester of rp-nucleoside analog
|
|
WO2014099941A1
(en)
|
2012-12-19 |
2014-06-26 |
Idenix Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
|
EP2970358B1
(en)
|
2013-03-04 |
2021-06-30 |
Idenix Pharmaceuticals LLC |
3'-deoxy nucleosides for the treatment of hcv
|
|
WO2014137930A1
(en)
|
2013-03-04 |
2014-09-12 |
Idenix Pharmaceuticals, Inc. |
Thiophosphate nucleosides for the treatment of hcv
|
|
WO2014165542A1
(en)
|
2013-04-01 |
2014-10-09 |
Idenix Pharmaceuticals, Inc. |
2',4'-fluoro nucleosides for the treatment of hcv
|
|
EP3004130B1
(en)
|
2013-06-05 |
2019-08-07 |
Idenix Pharmaceuticals LLC. |
1',4'-thio nucleosides for the treatment of hcv
|
|
EP3027636B1
(en)
|
2013-08-01 |
2022-01-05 |
Idenix Pharmaceuticals LLC |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
|
PT3038601T
(pt)
|
2013-08-27 |
2020-06-30 |
Gilead Pharmasset Llc |
Formulação combinada de dois compostos antivirais
|
|
WO2015042375A1
(en)
|
2013-09-20 |
2015-03-26 |
Idenix Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
WO2015061683A1
(en)
|
2013-10-25 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate and d-alanine thiophosphoramidate pronucleotides of nucleoside compounds useful for the treatment of hcv
|
|
WO2015066370A1
(en)
|
2013-11-01 |
2015-05-07 |
Idenix Pharmaceuticals, Inc. |
D-alanine phosphoramidate pronucleotides of 2'-methyl 2'-fluoro guanosine nucleoside compounds for the treatment of hcv
|
|
WO2015081297A1
(en)
|
2013-11-27 |
2015-06-04 |
Idenix Pharmaceuticals, Inc. |
2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection
|
|
US10683321B2
(en)
|
2013-12-18 |
2020-06-16 |
Idenix Pharmaceuticals Llc |
4′-or nucleosides for the treatment of HCV
|
|
EP3114122A1
(en)
|
2014-03-05 |
2017-01-11 |
Idenix Pharmaceuticals LLC |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
|
WO2015134561A1
(en)
|
2014-03-05 |
2015-09-11 |
Idenix Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infection
|
|
EP3131914B1
(en)
|
2014-04-16 |
2023-05-10 |
Idenix Pharmaceuticals LLC |
3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
|
|
KR102672910B1
(ko)
|
2017-01-10 |
2024-06-07 |
오웬-배리 파머소티컬즈 인코포레이티드 |
항경련 화합물
|
|
ES2812698T3
(es)
|
2017-09-29 |
2021-03-18 |
Probiodrug Ag |
Inhibidores de glutaminil ciclasa
|
|
EP4475953A1
(en)
|
2022-02-08 |
2024-12-18 |
Fikret SAHIN |
Nmdar antagonists prevent ageing and aging-associated conditions and diseases through increasing 20s proteasome activity
|
|
CN117658827A
(zh)
*
|
2022-09-01 |
2024-03-08 |
上海睿智化学研究有限公司 |
烷基环己基乙胺的合成方法
|